3—Other side effects (fluid retention, weight gain and bad cholesterol) some patients get from taking Avandia; all can contribute to heart problems.

43%—Greater chance of heart attacks among Avandia users.

61—Heart-related deaths suffered by Avandia users in the GlaxoSmithKline studies.

64%—Greater risk of death from heart problems among Avandia users.

81%—Greater risk of bone fractures among women who take Avandia, as compared with a generic diabetes drug.

158—Heart attacks suffered by Avandia users in the GSK studies.

900%—Increase in trading volume of GSK on Wall Street soon after Dr. David Nissen’s findings were published in the May 2007 issue of the NEJM.

13,000—The approximate number of Avandia lawsuits that have been filed as of July 2010.

13 million—Prescriptions written for Avandia in 2006.

18 million—Type 2 diabetics in the United States.

60 million—Prescriptions written for Avandia since it went on the market in 1999.

$3.2 billion—Sales of Avandia in 2006.